Advertisement

Month: December 2012

Exercise Testing After PCI

Recurrent ischemia and cardiac events are common after PCI and CABG, signifying that coronary artery disease may still be progressing. Guidelines from the American College of Cardiology and the American Heart Association suggest...

Read More

FDA Approves Eliquis Anti-Clotting Drug

The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation...

Read More

Disparities Persist for Rural Cancer Survivors

An analysis from Wake Forest University suggests that cancer survivors living in rural areas of the United States are at greater risk for poor health outcomes when compared with survivors from urban areas. When compared with...

Read More

Examining Serious Cardiac Arrhythmias After Stroke

A German study team has found that significant cardiac arrhythmias following an acute cerebrovascular event appear most likely to occur during the first 24 hours of care, but this risk decreases over the next 3 days. Among acute...

Read More

Enhancing Consultations in the ED

In EDs nationwide, consultations between emergency physicians (EPs) and other doctors or specialists for advice or intervention regarding patient care occur on a daily basis. Emergency medicine (EM) consultation is an important...

Read More

Bedside Tool Helps Predict Outcomes After Stroke

A clinical prediction rule for death and severe disability after acute ischemic stroke— derived from preadmission comorbidities, level of consciousness, age, and neurologic deficit—appears to identify patients who will have poor...

Read More

Candidemia: Incidence & Antifungal Drug Resistance

During the past 20 years, adults aged 65 and older appear to have replaced infants as having the highest incidence of candidemia, according to CDC investigators. The authors noted that incidence rates declined significantly for...

Read More

Advertisement

For latest news and updates
Email-id is invalid